11.07.2018 Views

The Economic Consequences of Opioid Addiction in America

The Economic Consequences of Opioid Addiction in America

The Economic Consequences of Opioid Addiction in America

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

access to medication-assisted treatment (MAT) services for persons with an<br />

opioid use disorder (OUD) seek<strong>in</strong>g or receiv<strong>in</strong>g MAT. This program’s focus is on<br />

fund<strong>in</strong>g organizations and tribes/tribal organizations with<strong>in</strong> states identified as<br />

hav<strong>in</strong>g the highest rates <strong>of</strong> primary treatment admissions for hero<strong>in</strong> and opioids<br />

per capita and <strong>in</strong>cludes those states with the most dramatic <strong>in</strong>creases for hero<strong>in</strong><br />

and opioids, based on SAMHSA’s 2015 Treatment Episode Data Set (TEDS).<br />

Application Deadl<strong>in</strong>e: July 9, 2018<br />

<br />

<br />

<br />

<br />

Rural Communities <strong>Opioid</strong> Response-Plann<strong>in</strong>g Program: Through its parent<br />

agency, the Health Resources and Services Adm<strong>in</strong>istration (HRSA), the Federal<br />

Office <strong>of</strong> Rural Health Policy (FORHP) will make awards <strong>of</strong> up to $200,000 each<br />

to support one year <strong>of</strong> community-level plann<strong>in</strong>g for prevention and treatment <strong>of</strong><br />

opioid use disorder <strong>in</strong> approximately 75 high-risk rural communities. Successful<br />

awardees will partner with at least three other separately-owned entities and<br />

develop plans to implement opioid use disorder prevention, treatment, and<br />

recovery <strong>in</strong>terventions. This program is part <strong>of</strong> a multi-year, $130 million opioidfocused<br />

effort by HRSA. Application Deadl<strong>in</strong>e: July 30, 2018<br />

National Health Emergency (NHE) Dislocated Worker Demonstration Grants:<br />

TEGL-12-17 (Issued on March 20, 2018): ETA announces the availability <strong>of</strong> $21<br />

million for National Health Emergency Dislocated Worker Demonstration Grants.<br />

<strong>The</strong> purpose <strong>of</strong> these grants is to enable eligible applicants to serve or retra<strong>in</strong><br />

workers <strong>in</strong> communities impacted by the health and economic effects <strong>of</strong><br />

widespread opioid use, addiction, and overdose. ETA anticipates award<strong>in</strong>g 7 to<br />

10 demonstration projects, with expected fund<strong>in</strong>g amounts between $500,000<br />

and $5 million each. No award will exceed $5 million. <strong>The</strong> f<strong>in</strong>al amount <strong>of</strong> each<br />

grant will be dependent on the number <strong>of</strong> applicants and the availability <strong>of</strong><br />

Federal funds. Eligible applicants for NHE grants are limited to the same as<br />

those eligible for Disaster Recovery DWGs, under 20 C.F.R. 687.120: state<br />

workforce agencies; outly<strong>in</strong>g areas; and, Indian tribal governments as def<strong>in</strong>ed by<br />

the Robert T. Stafford Disaster Relief and Emergency Assistance Act (42 U.S.C.<br />

5122(6)). Application Deadl<strong>in</strong>e: July 31, 2018<br />

Tribal <strong>Opioid</strong> Response Grants: <strong>The</strong> Substance Abuse and Mental Health<br />

Services Adm<strong>in</strong>istration (SAMHSA) is accept<strong>in</strong>g applications for fiscal year (FY)<br />

2018 Tribal <strong>Opioid</strong> Response grants (Short Title: TOR). <strong>The</strong> program aims to<br />

address the opioid crisis <strong>in</strong> tribal communities by <strong>in</strong>creas<strong>in</strong>g access to culturally<br />

appropriate and evidence-based treatment, <strong>in</strong>clud<strong>in</strong>g medication-assisted<br />

treatment (MAT) us<strong>in</strong>g one <strong>of</strong> the three FDA-approved medications for the<br />

treatment <strong>of</strong> opioid use disorder (OUD). <strong>The</strong> <strong>in</strong>tent is to reduce unmet treatment<br />

need and opioid overdose related deaths through the provision <strong>of</strong> prevention,<br />

treatment and/or recovery activities for OUD. Application Deadl<strong>in</strong>e: August 20,<br />

2018<br />

Federal Office <strong>of</strong> Rural Health Policy Call For Reviewers: <strong>The</strong> Health Resources<br />

and Services Adm<strong>in</strong>istration (HRSA) relies on grant reviewers to select the best<br />

Page 93 <strong>of</strong> 159

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!